Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Scott

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Nature Communications|January 26, 2016
Functional annotation of rare gene aberration drivers of pancreatic cancerYiu Huen Tsang, Turgut Dogruluk, Philip M Tedeschi, et al.
Genome Research|October 3, 2012
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancerHan Liang, Lydia W T Cheung, Jie Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2018
Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2Byung-Kwon Choi, Tajhal Dayaram, Neha Parikh, et al.
The Journal of Clinical Investigation|February 10, 2015
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stromaYulong Chen, Masahiko Terajima, Yanan Yang, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2<sup>+</sup> Breast CancerXiaowei Xu, Carmine De Angelis, Kathleen A Burke, et al.
Cell|January 12, 2019
Bacteria-to-Human Protein Networks Reveal Origins of Endogenous DNA DamageJun Xia, Li-Ya Chiu, Ralf B Nehring, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Science Translational Medicine|January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinomaXiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Nature Communications|January 26, 2016
Functional annotation of rare gene aberration drivers of pancreatic cancerYiu Huen Tsang, Turgut Dogruluk, Philip M Tedeschi, et al.
Genome Research|October 3, 2012
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancerHan Liang, Lydia W T Cheung, Jie Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2018
Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2Byung-Kwon Choi, Tajhal Dayaram, Neha Parikh, et al.
The Journal of Clinical Investigation|February 10, 2015
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stromaYulong Chen, Masahiko Terajima, Yanan Yang, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2<sup>+</sup> Breast CancerXiaowei Xu, Carmine De Angelis, Kathleen A Burke, et al.
Cell|January 12, 2019
Bacteria-to-Human Protein Networks Reveal Origins of Endogenous DNA DamageJun Xia, Li-Ya Chiu, Ralf B Nehring, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Science Translational Medicine|January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinomaXiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Pageof 6